Regulation of tenascin-C expression in bone cells by transforming growth factor-β

Bone

Volumn 22, Issue 4, 1998, Pages 301-307

  MacKie, E J ^a   Abraham, L A ^b   Taylor, S L ^b   Tucker, R P ^c   Murphy, L I ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone; Extrucellular matrix; Osteoblast; Tenascin C; Transforming growth factor

Indexed keywords

MESSENGER RNA; SCLEROPROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE CELL; CALVARIA; CONTROLLED STUDY; DENSITOMETRY; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NORTHERN BLOTTING; OSSIFICATION; OSTEOSARCOMA CELL; PERIOSTEUM; PROTEIN EXPRESSION;

ANIMALS; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; MICE, INBRED BALB C; OSTEOBLASTS; OSTEOGENESIS; PARIETAL BONE; SKULL; TENASCIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032055380     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(97)00297-4     Document Type: Article

References (42)

1. Andrianarivo A. G., Robinson J. A., Mann K. G., Tracy R. P. Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells. J Cell Physiol. 153:1992;256-265.
2. Celic S., Chilco P. J., Zajac J. D., Martin T. J., Findlay D. M. A type I collagen substrate increases PTH/PTHrP receptor mRNA expression and suppresses PTHrP mRNA expression in UMR-106-06 osteoblast-like cells. J Endocrinol. 150:1996;299-308.
3. Centrella M., McCarthy T. L., Canalis E. Transforming growth factor-β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem. 262:1987;2869-2874.
4. Chiquet-Ehrismann R., Hagios C., Matsumoto K. I. The tenascin gene family. Perspect Dev Neurobiol. 2:1994;3-7.
5. Chiquet-Ehrismann R., Hagios C., Schenk S. The complexity in regulating the expression of tenascins. BioEssays. 17:1995;873-878.
6. Critchlow M. A., Bland Y. S., Ashhurst D. E. The effects of age on the response of rabbit periosteal osteoprogenitor cells to exogenous transforming growth factor-β2. J Cell Sci. 107:1994;499-516.
7. Fischer, D., Tucker, R. P., Chiquet-Ehrismann, R., and Adams, J. C. Cell adhesive responses to tenascin-C splice variants involve formation of fascin microspikes. Mol Biol Cell. In press.
8. Forsberg E., Hirsch E., Fröhlich L., Meyer M., Ekblom P., Aszodi A., Werner S., Fässler R. Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc Natl Acad Sci USA. 93:1996;6594-6599.
9. Fukamauchi F., Mataga N., Wang Y.-J., Sato S., Yoshiki A., Kusakabe M. Abnormal behaviour and neurotransmissions of tenascin gene knockout mouse. Biochem Biophys Res Commun. 221:1996;151-156.
10. Gehron Robey P., Young M. F., Flanders K. C., Roche N. S., Kondaiah P., Reddi A. H., Termine J. D., Sporn M. B., Roberts A. B. Osteoblasts synthesize and respond to transforming growth factor-type β (TGF-β) in vitro. J Cell Biol. 105:1987;457-463.
11. Hughes F. J., Aubin J. E., Heersche J. N. M. Differential chemotactic responses of different populations of fetal rat calvarial cells to PDGF and TGF-β Bone Miner. 19:1992;63-74.
12. Joyce M. E., Roberts A. B., Sporn M. B., Bolander M. E. Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol. 110:1990;2195-2207.
13. Kiernan B. W., Götz B., Faissner A., ffrench-Constant C. Tenascin-C inhibits oligodendrocyte precursor cell migration by both adhesion-dependent and adhesion-independent mechanisms. Molec Cell Neurosci. 7:1996;322-335.
14. Klein-Nulend J., Roelofsen J., Sterck J. G. H., Semeins C. M., Burger E. H. Mechanical loading stimulates the release of transforming growth factor-β activity by cultured mouse calvariae and periosteal cells. J Cell Physiol. 163:1995;115-119.
15. Kwan K. M., Pang M. K. M., Zhou S., Cowan S. K., Kong R. Y. C., Pfordte T., Olsen B. R., Sillence D. O., Tam P. P. L., Cheah K. S. E. Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X Implications for function . J Cell Biol. 136:1997;459-471.
16. Langdahl B. L., Knudsen J. Y., Jensen H. K., Gregersen N., Eriksen E. F. A sequence variation 713-8delC in the transforming growth factor-β1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women . Bone. 20:1997;289-294.
17. Leprini A., Querzé G., Zardi L. Tenascin isoforms Possible targets for diagnosis and therapy of cancer and mechanisms regulating their expression . Perspect Dev Neurobiol. 2:1994;117-123.
18. Linkhart T. A., Mohan S., Baylink D. J. Growth factors for bone growth and repair IGF, TGFβ, and BMP . Bone. 19:1996;1S-12S.
19. Lynch M. P., Stein J. L., Stein G. S., Lian J. B. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts Modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization . Exp Cell Res. 216:1995;35-45.
20. Mackie E. J., Halfter W., Liverani D. Induction of tenascin in healing wounds. J Cell Biol. 107:1988;2757-2767.
21. Mackie E. J., Ramsey S. Modulation of osteoblast behavior by tenascin. J Cell Sci. 109:1996;1597-1604.
22. Mackie E. J., Ramsey S. Expression of tenascin in joint-associated tissues during development and postnatal growth. J Anat. 188:1996;157-165.
23. Mackie E. J., Thesleff I., Chiquet-Ehrismann R. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol. 105:1987;2569-2579.
24. Mackie E. J., Trechsel U. Stimulation of bone formation in vivo by transforming growth factor-β Remodeling of woven bone and lack of inhibition by indomethacin . Bone. 11:1990;295-300.
25. Mackie E. J., Tucker R. P. Tenascin in bone morphogenesis Expression by osteoblasts and cell type-specific expression of splice variants . J Cell Sci. 103:1992;765-771.
26. Majeska R. J., Rodan S. B., Rodan G. A. Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology. 107:1980;1494-1504.
27. Marcelli C., Yates A. J., Mundy G. R. In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice. J Bone Miner Res. 10:1990;1087-1096.
28. Masi L., Franchi A., Santucci M., Danielli D., Arganini L., Giannone V., Formigli L., Benvenuti S., Tanini A., Beghè F., Mian M., Brandi M. L. Adhesion, growth, and matrix production by osteoblasts on collagen substrata. Calcif Tiss Int. 51:1992;202-212.
29. Noda M., Camilliere J. J. In vivo stimulation of bone formation by transforming growth factor-β Endocrinology. 124:1989;2991-2994.
30. Pfeilschifter J., Wolf O., Nautmann A., Minne H. W., Mundy G. R., Ziegler R. Chemotactic response of osteoblast-like cells to TGF-β J Bone Miner Res. 5:1990;825-830.
31. Prieto A. L., Jones F. S., Cunningham B. A., Crossin K. L., Edelman G. M. Localization during development of alternatively spliced forms of cytotactin mRNA by in situ hybridization. J Cell Biol. 111:1990;685-698.
32. Rosen D., Miller S. C., DeLeon E., Thompson A. Y., Bentz H., Mathews M., Adams S. Systemic administration of recombinant transforming growth factor beta 2 (rTGF-β2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone. 15:1994;355-359.
33. Saga Y., Yagi T., Ikawa Y., Sakakura T., Aizawa S. Mice develop normally without tenascin. Genes Dev. 6:1992;1821-1831.
34. Schwögler S., Odenthal M., Meyer zum Büschenfelde K.-H., Ramadori G. Alternative splicing products of the tenascin gene distinguish rat liver fat storing cells from arterial smooth muscle cells and skin fibroblasts. Biochem Biophys Res Commun. 185:1992;768-775.
35. Seyedin P. R., Thomas T. C., Thompson A. Y., Rosen D. M., Piez K. A. Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. Proc Natl Acad Sci USA. 82:1985;2267-2271.
36. Siri A., Knäuper V., Veirana N., Caocci F., Murphy G., Zardi L. Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem. 270:1995;8650-8654.
37. Sriramarao P., Bourdon M. A. A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices. Nucl Acids Res. 21:1993;163-168.
38. Thesleff I., Kantomaa T., Mackie E. J., Chiquet-Ehrismann R. Immunohistochemical localization of the matrix glycoprotein tenascin in the skull of the growing rodent. Arch Oral Biol. 33:1988;383-390.
39. Webb C. M. B., Zaman G., Mosley J. R., Tucker R. P., Lanyon L. E., Mackie E. J. Expression of tenascin-C in bones responding to mechanical load. J Bone Miner Res. 12:1997;52-58.
40. Weller A., Beck S., Ekblom P. Amino acid sequence of mouse tenascin and differential expression of two tenascin isoforms during embryogenesis. J Cell Biol. 112:1991;355-362.
41. Zhao Y., Young S. L. TGF-β regulates expression of tenascin alternative-splicing isoforms in fetal rat lung. Am J. Physiol. 268:1995;L173-L180.
42. Zhou H., Choong P. C., Chou S. T., Kartsogiannis V., Martin T. J., Ng K. W. Transforming growth factor β1 stimulates bone formation and resorption in an in-vivo model in rabbits. Bone. 17:1995;443S-448S.